¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"community infection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • latent infection
    Àẹ°¨¿°
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ¼º°¨¿°
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    º¹¼ö°¨¿°, ¿©·¯¹ø°¨¿°
  • mycotic infection
    °õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
  • mass infection
    Áý´Ü°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø°¨¿°
  • household infection
    Áý¾È°¨¿°
  • infection
    °¨¿°
  • inapparant infection
    ¹«Áõ»ó°¨¿°, ºÒÇö¼º°¨¿°
  • indigenous infection
    ÅäÂø°¨¿°
  • indirect infection
    °£Á¢°¨¿°
  • infection immunity
    °¨¿°¸é¿ª
  • infection route
    °¨¿°°æ·Î
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
  • infection control study
    °¨¿°°ü¸®Á¶»ç
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • insect-borne infection
    °ïÃæ¸Å°³°¨¿°
  • intercurrent infection
    º´¹ß°¨¿°
  • introduced infection
    µµÀÔ°¨¿°
  • latent infection
    Àẹ°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • indirect infection
    °£Á¢°¨¿°.
  • infection
    °¨¿°(Êïæø), Àü¿°(îîæø).
  • infection
    °¨¿°
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection by dirt
    ¿À¹°°¨¿°(çýÚªÊïæø).
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • infection focus
    °¨¿°¼Ò(Êïæøáµ).
  • infection immunity
    °¨¿°¸é¿ª.
  • infection route
    °¨¿°°æ·Î.
  • infection source
    °¨¿°¿ø(˧ËçËô), Àü¿°¿ø(ËøËçËô).
  • infection source
    °¨¿°¿ø(Êïæøê¹), Àü¿°¿ø(îîæøê¹).
  • infection, abortive
    ºÒ¹ß°¨¿°, ºÎÀü°¨¿°
  • infection, air-borne
    °ø±â¸Å°³°¨¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bacteroides infection
    ¹ÚÅ×·ÎÀ̵¥½º °¨¿°(Áõ) (¡­Êïæøñø).
  • cervical infection
    °æºÎ°¨¿°(ÌòÝ»Êïæø).
  • chlamydial infection
    Ŭ¶ó¹Ìµð¾Æ °¨¿°
  • chronic infection
    ¸¸¼º°¨¿°(Ø·àõÊïæø)
  • concurrent infection
    µ¿½Ã°¨¿°(¡­Êïæø).
  • congenital infection
    ¼±Ãµ°¨¿°
  • contact infection
    Á¢Ã˰¨¿°
  • contagious infection
    Á¢Ã˰¨¿°(¡­Êïæø), Á¢ÃËÀü¿°(¡­îîæø).
  • contagious infection
    Á¢Ã˰¨¿°(ÊÙ˧Ëç), Á¢ÃËÀü¿°(ÊÙËøËç).
  • cross infection
    ±³Â÷°¨¿°(Îßó©Êïæø).
  • cryptogenic infection
    Àẹ(¼º) °¨¿°(¡­Êïæø).
  • cycle, infection
    °¨¿°ÁÖ±â
  • cytomegalovirus infection
    »çÀÌÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø).
  • cytomegalovirus infection
    ½ÃÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø)
  • cytomegalovirus infection
    ½ÃÅä¸Þ°¥·Î¹ÙÀÌ·¯½º°¨¿°(¡­Êïæø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
C/MHC community/migrant health center
CNC community nursing center
CNH central neurogenic hyperpnea; community nursing home
CNO community nursing organization
CNP community nurse practitioner; continuous negative pressure; cranial nerve palsy; 2',3'-cyclic nucleo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CPCRA Community Programs for Clinical Research in AIDS
CPN Community Psychiatric Nurse
CSP Community Support Program
C/MHC Community and Migrant Health Center
CBO community based organization
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • salmonella infection
    »ì¸ð³Ú¶ó °¨¿°Áõ
  • septic infection
    ÆÐÇ÷¼º °¨¿°, ÆÐÇ÷Áõ¼º °¨¿°
  • Serratia infection
    ¼¿¶óƼ¾Æ °¨¿°Áõ
    ·¹À̱ÕÀ̶ó°í ÇÏ´Â ¼ÒÇüÀÇ ±×¶÷ À½¼º °£±Õ¿¡ ÀÇÇØ ÀϾ°í, ±âÃÊ ÁúȯÀ» °¡Áö´Â ȯÀÚÀÇ Á¾¸» °¨¿°À¸·Î¼­ º´¿ø¼ºÀ» ¹ßÇÑ´Ù.
  • slow virus infection
    ½½·Î¿ì ¹ÙÀÌ·¯½º °¨¿°
  • source of infection
    °¨¿°¿ø
  • staphylococcal infection
    Æ÷µµ»ó ±¸±Õ °¨¿°
  • upper respiratory infection
    »ó±âµµ °¨¿°
  • virus respiratory infection
    ¹ÙÀÌ·¯½º¼º È£Èí±â °¨¿°Áõ
  • water borne infection
    ¼öÀμº °¨¿°
  • water-borne infection
    ¼öÀμº °¨¿°, ¼öÀμº Àü¿°
  • waterborne infection
    ¼öÀμº Àü¿°º´
    ¹°
  • wound infection
    â»ó °¨¿°
  • zoonotic infection
    Àμö °øÅë °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
natural focus of infection An ecosystem in which an infectious agent normally persists in nature; e.g., yellow fever virus in a jungle monkey-Haemagogus mosquito ecosystem.
(05 Mar 2000)
subclinical infection <epidemiology> An infection in which symptoms are sufficiently mild or inapparent to escape diagnosis other than by positive confirmation of the ability to transmit the infection or serologically.
(05 Dec 1998)
nosocomial infection <microbiology> Hospital acquired infection: commonest are due to Staphylococcus aureus, Pseudomonas aeruginosa, E. Coli, Klebsiella pneumoniae, Serratia marcescens and Proteus mirabilis.
(18 Nov 1997)
surgical wound infection Infection occurring at the site of a surgical incision.
(12 Dec 1998)
disseminated gonococcal infection Infection from Neisseria gonorrhoea which is spread to distant parts of the body beyond the original portal of entry (usually the lower genital tract). Usually manifest by rash and arthritis.
(05 Mar 2000)
droplet infection Infection acquired through the inhalation of droplets or aerosols of saliva or sputum containing virus or other microorganisms expelled by another person during sneezing, coughing, laughing, or talking.
(05 Mar 2000)
inapparent infection Presence of infection in a host without the occurrence of recognizable symptoms or signs.
(05 Mar 2000)
infection 1. <microbiology> Invasion and multiplication of microorganisms in body tissues, which may be clinically unapparent or result in local cellular injury due to competitive metabolism, toxins, intracellular replication or antigen antibody response. The infection may remain localised, subclinical and temporary if the bodys defensive mechanisms are effective. A local infection may persist and spread by extension to become an acute, subacute or chronic clinical infection or disease state. A local infection may also become systemic when the microorganisms gain access to the lymphatic or vascular system.
2. An infectious disease.
(18 Nov 1997)
infection calculus A calculus associated with infection and/or obstruction, usually composed of struvite (magnesium ammonium phosphate).
Synonym: infection calculus.
(05 Mar 2000)
infection control Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.
(12 Dec 1998)
infection control, dental Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.
(12 Dec 1998)
infection control nurse A registered nurse with additional education in the monitoring and prevention of nosocomial infections in the client population in an agency.
Synonym: infection control nurse.
(05 Mar 2000)
infection control practitioners Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff.
(12 Dec 1998)
infection-exhaustion psychosis A psychosis following an acute infection, shock, or chronic intoxication; begins as delirium followed by pronounced mental confusion with hallucinations and unsystematised delusions, and sometimes stupor.
Synonym: febrile psychosis.
(05 Mar 2000)
infection immunity The paradoxical immune status in which resistance to reinfection coincides with the persistence of the original infection.
Synonym: concomitant immunity.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á